Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy

Idiopathic pulmonary fibrosis (IPF) is a rare and severe disease with a median survival of ~3 years. Nintedanib (NTD) has been shown to be useful in controlling interstitial lung disease (ILD) in IPF. Here we describe the experience of NTD use in IPF in a real-life setting. Objective. Our objective...

Full description

Saved in:
Bibliographic Details
Main Authors: Barbara Ruaro (Author), Ilaria Gandin (Author), Riccardo Pozzan (Author), Stefano Tavano (Author), Chiara Bozzi (Author), Michael Hughes (Author), Metka Kodric (Author), Rossella Cifaldi (Author), Selene Lerda (Author), Marco Confalonieri (Author), Elisa Baratella (Author), Paola Confalonieri (Author), Francesco Salton (Author)
Format: Book
Published: MDPI AG, 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available